Price movement over the last 24 hours
Bio Protocol vs EigenCloud — how do they compare? Bio Protocol trades at Rp521.46 (market cap Rp1,17T, Rp248,44M 24h volume), while EigenCloud trades at Rp4,472 (market cap Rp3,69T, Rp312,43M 24h volume). The key difference: EigenCloud is far larger — about 3.2× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while EigenCloud's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and EigenCloud for 25 Days on average.
| BIO | EIGEN | |
|---|---|---|
Market Cap | Rp1,17T | Rp3,69T |
Volume (24h) | Rp248,44M | Rp312,43M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 822,3M EIGEN |
Typical Hold Time | 16 Days | 25 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp521.46 with a market cap of Rp1.16T, showing bearish technical signals as moving averages indicate selling pressure while oscillators remain neutral. The token's circulating supply of 2.2M out of 3.3M max supply (68% circulation) suggests controlled token distribution. Current price sits near the pivot point of Rp521 with immediate support at Rp508 and resistance at Rp530. Recent market activity shows average hold time of 16 days, indicating relatively short-term trading patterns in the current bearish environment.
Overall outlook remains cautious with technical indicators favoring sellers, though oversold RSI conditions may present short-term bounce opportunities. Key risks include continued bearish momentum and low trading volumes, while potential upside could come from any positive ecosystem developments or market-wide crypto recovery. Investors should monitor support levels closely for entry points.
EigenCloud (EIGEN) is currently trading at Rp4,212 with a market cap of Rp3.47 trillion, showing a bullish technical signal supported by moving averages. Key resistance lies at Rp4,304 and support at Rp3,957. The RSI indicates neutral momentum while ADX suggests a strong trend. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook is cautiously optimistic due to bullish technicals, but limited fundamental catalysts and typical crypto volatility pose risks. Investors should monitor support levels and await new network activity for sustained growth.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →The EIGEN token is a universal work token designed for EigenLayer, providing security for various digital tasks that are not only objectively verifiable but also intersubjectively attributable. Unlike traditional work tokens that are tied to specific digital tasks or objective faults that are verifiable on-chain, EIGEN addresses a broader category of faults where multiple external observers agree on whether the task was performed correctly. This expands the range of tasks that can be securely managed on a blockchain. EIGEN tokens are used for identifying intersubjective faults on the EigenLayer platform, performing validation tasks across various Actively Validated Services (AVS), and incentivizing and penalizing operators based on their performance.
Read more on EIGEN →